HEADER HYDROLASE 22-AUG-06 2I4Q TITLE HUMAN RENIN/PF02342674 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RENIN INHIBITOR, PROTEIN-LIGAND COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.D.HOLSWORTH,M.JALAIE,E.ZHANG,P.MCCONNELL,I.MOCHALKIN,B.C.FINZEL REVDAT 4 30-OCT-24 2I4Q 1 REMARK SEQADV REVDAT 3 02-MAR-10 2I4Q 1 JRNL REVDAT 2 24-FEB-09 2I4Q 1 VERSN REVDAT 1 24-OCT-06 2I4Q 0 JRNL AUTH N.A.POWELL,F.L.CISKE,C.CAI,D.D.HOLSWORTH,K.MENNEN, JRNL AUTH 2 C.A.VAN HUIS,M.JALAIE,J.DAY,M.MASTRONARDI,P.MCCONNELL, JRNL AUTH 3 I.MOCHALKIN,E.ZHANG,M.J.RYAN,J.BRYANT,W.COLLARD,S.FERREIRA, JRNL AUTH 4 C.GU,R.COLLINS,J.J.EDMUNDS JRNL TITL RATIONAL DESIGN OF JRNL TITL 2 6-(2,4-DIAMINOPYRIMIDINYL)-1,4-BENZOXAZIN-3-ONES AS SMALL JRNL TITL 3 MOLECULE RENIN INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 15 5912 2007 JRNL REFN ISSN 0968-0896 JRNL PMID 17574423 JRNL DOI 10.1016/J.BMC.2007.05.069 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.8 REMARK 3 NUMBER OF REFLECTIONS : 37709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1919 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2771 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 160 REMARK 3 BIN FREE R VALUE : 0.3840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.347 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.248 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.169 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.948 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5386 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4732 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7320 ; 1.080 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11024 ; 0.718 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 670 ; 6.581 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 808 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6012 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1120 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 899 ; 0.171 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5375 ; 0.214 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3281 ; 0.080 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 162 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.212 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 100 ; 0.253 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.142 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3316 ; 0.828 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5364 ; 1.458 ; 3.500 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2070 ; 0.610 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1956 ; 1.055 ; 3.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2I4Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039134. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 170 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37838 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 200 DATA REDUNDANCY : 2.630 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.94900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.94900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 70.94900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.94900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.94900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 70.94900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 70.94900 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 70.94900 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 70.94900 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 70.94900 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 70.94900 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 70.94900 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 70.94900 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 70.94900 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 70.94900 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 70.94900 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 70.94900 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 70.94900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS ENTRY CONTAINS A DIMER IN THE ASYMMETRIC UNIT THAT REMARK 300 CONSTITUTES A BIOLOGICALLY ACTIVE SPECIES REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 335 O REMARK 470 ARG B 335 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN B 70 O LEU B 87 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 12 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 160 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 323 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 160 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 323 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 70 -62.18 -133.70 REMARK 500 SER A 207 53.64 -98.77 REMARK 500 SER A 208 141.19 -172.29 REMARK 500 ASP A 214 -14.67 77.14 REMARK 500 ALA A 294 34.65 -83.71 REMARK 500 ASN B 70 91.19 -172.27 REMARK 500 MET B 109 89.08 -152.64 REMARK 500 GLN B 165 49.58 -106.91 REMARK 500 ARG B 246 -74.30 -59.85 REMARK 500 LEU B 247 -55.63 -148.39 REMARK 500 ALA B 294 33.08 -86.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UA4 B 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UA4 A 336 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G24 RELATED DB: PDB REMARK 900 KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING REMARK 900 RELATED ID: 2G21 RELATED DB: PDB REMARK 900 KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING REMARK 900 RELATED ID: 2G1S RELATED DB: PDB REMARK 900 KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING DBREF 2I4Q A 2 335 UNP P00797 RENI_HUMAN 71 406 DBREF 2I4Q B 2 335 UNP P00797 RENI_HUMAN 71 406 SEQADV 2I4Q ASN A 0 UNP P00797 CLONING ARTIFACT SEQADV 2I4Q THR A 1 UNP P00797 CLONING ARTIFACT SEQADV 2I4Q ASN B 0 UNP P00797 CLONING ARTIFACT SEQADV 2I4Q THR B 1 UNP P00797 CLONING ARTIFACT SEQRES 1 A 336 ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET ASP SEQRES 2 A 336 THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO PRO SEQRES 3 A 336 GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER ASN SEQRES 4 A 336 VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR THR SEQRES 5 A 336 ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SER SEQRES 6 A 336 SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU ARG SEQRES 7 A 336 TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN ASP SEQRES 8 A 336 ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET PHE SEQRES 9 A 336 GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET LEU SEQRES 10 A 336 ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE GLU SEQRES 11 A 336 GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN ILE SEQRES 12 A 336 ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER PHE SEQRES 13 A 336 TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU GLY SEQRES 14 A 336 GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS TYR SEQRES 15 A 336 GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR GLY SEQRES 16 A 336 VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SER SEQRES 17 A 336 SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU VAL SEQRES 18 A 336 ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SER SEQRES 19 A 336 ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS ARG SEQRES 20 A 336 LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO THR SEQRES 21 A 336 LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU TYR SEQRES 22 A 336 THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER TYR SEQRES 23 A 336 SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA MET SEQRES 24 A 336 ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU GLY SEQRES 25 A 336 ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP ARG SEQRES 26 A 336 ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 336 ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET ASP SEQRES 2 B 336 THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO PRO SEQRES 3 B 336 GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER ASN SEQRES 4 B 336 VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR THR SEQRES 5 B 336 ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP SER SEQRES 6 B 336 SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU ARG SEQRES 7 B 336 TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN ASP SEQRES 8 B 336 ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET PHE SEQRES 9 B 336 GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET LEU SEQRES 10 B 336 ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE GLU SEQRES 11 B 336 GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN ILE SEQRES 12 B 336 ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER PHE SEQRES 13 B 336 TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU GLY SEQRES 14 B 336 GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS TYR SEQRES 15 B 336 GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR GLY SEQRES 16 B 336 VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY SER SEQRES 17 B 336 SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU VAL SEQRES 18 B 336 ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER SER SEQRES 19 B 336 ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS ARG SEQRES 20 B 336 LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO THR SEQRES 21 B 336 LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU TYR SEQRES 22 B 336 THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER TYR SEQRES 23 B 336 SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA MET SEQRES 24 B 336 ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU GLY SEQRES 25 B 336 ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP ARG SEQRES 26 B 336 ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG HET UA4 A 336 35 HET UA4 B 336 35 HETNAM UA4 (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5- HETNAM 2 UA4 DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2-METHYL-2H-1,4- HETNAM 3 UA4 BENZOXAZIN-3(4H)-ONE FORMUL 3 UA4 2(C25 H27 F2 N5 O3) FORMUL 5 HOH *190(H2 O) HELIX 1 1 TYR A 50 TYR A 55 1 6 HELIX 2 2 ASP A 60 SER A 64 5 5 HELIX 3 3 PRO A 110 MET A 115 1 6 HELIX 4 4 PHE A 127 VAL A 135 5 9 HELIX 5 5 PRO A 137 SER A 144 1 8 HELIX 6 6 ASP A 177 GLN A 179 5 3 HELIX 7 7 SER A 230 GLY A 242 1 13 HELIX 8 8 ASN A 255 LEU A 260 5 6 HELIX 9 9 THR A 275 VAL A 280 1 6 HELIX 10 10 GLY A 311 LYS A 317 1 7 HELIX 11 11 TYR B 50 TYR B 55 1 6 HELIX 12 12 ASP B 60 SER B 64 5 5 HELIX 13 13 PRO B 110 MET B 115 1 6 HELIX 14 14 PHE B 127 VAL B 135 5 9 HELIX 15 15 PRO B 137 GLN B 145 1 9 HELIX 16 16 ASP B 177 TYR B 181 5 5 HELIX 17 17 SER B 230 GLY B 242 1 13 HELIX 18 18 ASN B 255 LEU B 260 5 6 HELIX 19 19 THR B 275 VAL B 280 1 6 HELIX 20 20 GLY B 311 LYS B 317 1 7 SHEET 1 A 9 LYS A 68 TYR A 78 0 SHEET 2 A 9 GLY A 81 VAL A 94 -1 O GLN A 89 N LYS A 68 SHEET 3 A 9 GLN A 14 ILE A 21 -1 N GLY A 20 O THR A 93 SHEET 4 A 9 SER A 3 TYR A 10 -1 N THR A 8 O TYR A 16 SHEET 5 A 9 GLY A 169 LEU A 173 -1 O ILE A 171 N VAL A 5 SHEET 6 A 9 VAL A 152 TYR A 157 -1 N TYR A 156 O GLN A 170 SHEET 7 A 9 PHE A 318 ASP A 323 -1 O PHE A 322 N PHE A 153 SHEET 8 A 9 ARG A 328 ALA A 334 -1 O GLY A 330 N GLU A 321 SHEET 9 A 9 TYR A 181 ASN A 189 -1 N ILE A 188 O ILE A 329 SHEET 1 B13 LYS A 68 TYR A 78 0 SHEET 2 B13 GLY A 81 VAL A 94 -1 O GLN A 89 N LYS A 68 SHEET 3 B13 ILE A 97 GLU A 108 -1 O GLU A 105 N PHE A 86 SHEET 4 B13 VAL A 39 PRO A 42 1 N VAL A 39 O GLY A 104 SHEET 5 B13 GLY A 121 GLY A 124 -1 O VAL A 122 N TRP A 40 SHEET 6 B13 GLN A 26 ASP A 33 1 N VAL A 31 O VAL A 123 SHEET 7 B13 GLN A 14 ILE A 21 -1 N GLY A 17 O VAL A 30 SHEET 8 B13 SER A 3 TYR A 10 -1 N THR A 8 O TYR A 16 SHEET 9 B13 GLY A 169 LEU A 173 -1 O ILE A 171 N VAL A 5 SHEET 10 B13 VAL A 152 TYR A 157 -1 N TYR A 156 O GLN A 170 SHEET 11 B13 PHE A 318 ASP A 323 -1 O PHE A 322 N PHE A 153 SHEET 12 B13 ARG A 328 ALA A 334 -1 O GLY A 330 N GLU A 321 SHEET 13 B13 TYR A 181 ASN A 189 -1 N ILE A 188 O ILE A 329 SHEET 1 C 5 GLN A 197 MET A 200 0 SHEET 2 C 5 CYS A 216 VAL A 220 -1 O ALA A 218 N ILE A 198 SHEET 3 C 5 TRP A 308 LEU A 310 1 O LEU A 310 N LEU A 219 SHEET 4 C 5 ILE A 227 GLY A 229 -1 N SER A 228 O ALA A 309 SHEET 5 C 5 ILE A 295 ALA A 297 1 O HIS A 296 N ILE A 227 SHEET 1 D 3 GLY A 202 VAL A 205 0 SHEET 2 D 3 ILE A 263 LEU A 267 -1 O HIS A 266 N GLY A 202 SHEET 3 D 3 LYS A 270 LEU A 274 -1 O LEU A 274 N ILE A 263 SHEET 1 E 3 LYS A 244 LYS A 245 0 SHEET 2 E 3 TYR A 250 LYS A 253 -1 O VAL A 251 N LYS A 244 SHEET 3 E 3 LEU A 290 THR A 292 -1 O CYS A 291 N VAL A 252 SHEET 1 F 9 LYS B 68 ARG B 77 0 SHEET 2 F 9 THR B 82 VAL B 94 -1 O VAL B 83 N LEU B 76 SHEET 3 F 9 GLN B 14 ILE B 21 -1 N GLY B 20 O THR B 93 SHEET 4 F 9 SER B 3 TYR B 10 -1 N THR B 8 O TYR B 16 SHEET 5 F 9 GLY B 169 LEU B 173 -1 O LEU B 173 N SER B 3 SHEET 6 F 9 VAL B 152 TYR B 157 -1 N TYR B 156 O GLN B 170 SHEET 7 F 9 PHE B 318 ASP B 323 -1 O PHE B 322 N PHE B 153 SHEET 8 F 9 ARG B 328 LEU B 333 -1 O GLY B 330 N GLU B 321 SHEET 9 F 9 HIS B 186 ASN B 189 -1 N ILE B 188 O ILE B 329 SHEET 1 G13 LYS B 68 ARG B 77 0 SHEET 2 G13 THR B 82 VAL B 94 -1 O VAL B 83 N LEU B 76 SHEET 3 G13 ILE B 97 GLU B 108 -1 O GLU B 105 N PHE B 86 SHEET 4 G13 VAL B 39 PRO B 42 1 N VAL B 41 O GLY B 104 SHEET 5 G13 GLY B 121 GLY B 124 -1 O VAL B 122 N TRP B 40 SHEET 6 G13 GLN B 26 ASP B 33 1 N VAL B 31 O VAL B 123 SHEET 7 G13 GLN B 14 ILE B 21 -1 N GLY B 17 O VAL B 30 SHEET 8 G13 SER B 3 TYR B 10 -1 N THR B 8 O TYR B 16 SHEET 9 G13 GLY B 169 LEU B 173 -1 O LEU B 173 N SER B 3 SHEET 10 G13 VAL B 152 TYR B 157 -1 N TYR B 156 O GLN B 170 SHEET 11 G13 PHE B 318 ASP B 323 -1 O PHE B 322 N PHE B 153 SHEET 12 G13 ARG B 328 LEU B 333 -1 O GLY B 330 N GLU B 321 SHEET 13 G13 HIS B 186 ASN B 189 -1 N ILE B 188 O ILE B 329 SHEET 1 H 5 GLN B 197 MET B 200 0 SHEET 2 H 5 CYS B 216 VAL B 220 -1 O ALA B 218 N ILE B 198 SHEET 3 H 5 TRP B 308 LEU B 310 1 O LEU B 310 N LEU B 219 SHEET 4 H 5 ILE B 227 GLY B 229 -1 N SER B 228 O ALA B 309 SHEET 5 H 5 ILE B 295 ALA B 297 1 O HIS B 296 N ILE B 227 SHEET 1 I 3 VAL B 203 VAL B 205 0 SHEET 2 I 3 ILE B 263 LEU B 267 -1 O SER B 264 N SER B 204 SHEET 3 I 3 LYS B 270 LEU B 274 -1 O LEU B 274 N ILE B 263 SHEET 1 J 3 LYS B 244 LYS B 245 0 SHEET 2 J 3 TYR B 250 LYS B 253 -1 O VAL B 251 N LYS B 244 SHEET 3 J 3 LEU B 290 THR B 292 -1 O CYS B 291 N VAL B 252 SSBOND 1 CYS A 46 CYS A 53 1555 1555 2.02 SSBOND 2 CYS A 212 CYS A 216 1555 1555 2.04 SSBOND 3 CYS A 254 CYS A 291 1555 1555 2.04 SSBOND 4 CYS B 46 CYS B 53 1555 1555 2.03 SSBOND 5 CYS B 212 CYS B 216 1555 1555 2.04 SSBOND 6 CYS B 254 CYS B 291 1555 1555 2.04 CISPEP 1 THR A 23 PRO A 24 0 -1.19 CISPEP 2 LEU A 112 PRO A 113 0 5.38 CISPEP 3 PRO A 302 PRO A 303 0 3.13 CISPEP 4 GLY A 305 PRO A 306 0 1.26 CISPEP 5 THR B 23 PRO B 24 0 -0.58 CISPEP 6 LEU B 112 PRO B 113 0 2.84 CISPEP 7 PRO B 302 PRO B 303 0 2.59 CISPEP 8 GLY B 305 PRO B 306 0 -7.43 SITE 1 AC1 15 THR B 13 GLN B 14 TYR B 15 VAL B 31 SITE 2 AC1 15 ASP B 33 TYR B 78 THR B 80 PRO B 113 SITE 3 AC1 15 LEU B 116 ALA B 117 ASP B 221 THR B 222 SITE 4 AC1 15 GLY B 223 SER B 225 ASN B 255 SITE 1 AC2 16 THR A 13 GLN A 14 TYR A 15 VAL A 31 SITE 2 AC2 16 ASP A 33 TYR A 55 TYR A 78 SER A 79 SITE 3 AC2 16 THR A 80 LEU A 116 ALA A 117 VAL A 122 SITE 4 AC2 16 ASP A 221 THR A 222 GLY A 223 SER A 225 CRYST1 141.898 141.898 141.898 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007047 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007047 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007047 0.00000